|
PHENYTOIN SERUM LEVELS ARE INCREASED BY THE DRUG
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
CHLOROPROCAIN METABOLITE ( PARA-AMINOBENZOIC ACID) INHIBITS THE ACTION OF SULPHONAMIDES, HENCE SHOULD NOT BE CO-ADMINISTERED
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED ANTICOAGULANT EFFECTS ; THESE EFFECTS MAY BE PRONOUNCED IN THE ELDERLY
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED ANTICOAGULANT EFFECTS ; THESE EFFECTS MAY BE PRONOUNCED IN THE ELDERLY
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED ANTICOAGULANT EFFECTS ; THESE EFFECTS MAY BE PRONOUNCED IN THE ELDERLY
|
RENAL CLEARANCE MEASUREMENT CAN NOT BE MADE WITH ACCURACY IN PATIENTS RECEIVING THIS DRUG DUE TO INTERFERENCE WITH CHEMICAL COLOR DEVELOPMENT ESSENTIAL TO ANALYTICAL PROCEDURES
|